Training next level scientists and researchers to develop highly selective and safe insecticides - CypTox

Project Details

Description

Insecticides are substances that help eliminate insects and mites that cause human diseases such as malaria. While there are benefits to their use, they can also pose a serious threat to both wildlife and humans, for example through toxic residues in food and water. This issue has encouraged research into the creation of low-risk insecticides. One area research has explored is the role of the enzyme cytochrome P450 (CYP) in the sensitivity to insecticides. The EU-funded CypTox project will exploit the CYP metabolic/detoxification pathway of target and non-target organisms in order to develop insecticides that are highly selective and safe. The project’s work will also lead to state-of-the-art biotechnology platforms.
AcronymCypTox
StatusActive
Effective start/end date1/01/2131/12/24

Collaborative partners

  • Universitat Autònoma de Barcelona (UAB)
  • Idryma Technologias Kai Erevnas (Forth) (Coordinator) (lead)
  • Agricultural University of Athens (Project partner)
  • Endura Spa (Project partner)
  • Magma Antiprosopeysi kai emporia Georgikon Proionton Kai Efodion (EISROES) (Project partner)
  • University of Valencia (UV) (Project partner)
  • Cypex Limited (Project partner)
  • Ghent University (Universiteit Gent) (Project partner)
  • University of Exeter (Project partner)
  • Enzyquest Private Company (Project partner)
  • Universitat Autònoma de Barcelona (UAB) (Project partner)
  • Bionos Biotech SL (Project partner)
  • Devgen nv (Project partner)
  • Syngenta Crop Protection AG (Project partner)
  • The International Centre of Insect Physiology and Ecology LBG (ICIPE) (Project partner)
  • Syngenta Limited (Project partner)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.